{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:23:36Z","timestamp":1788870216884,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ministry of Science and Technology","award":["2009CB918400"],"award-info":[{"award-number":["2009CB918400"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30630034"],"award-info":[{"award-number":["30630034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["90813034"],"award-info":[{"award-number":["90813034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30870523"],"award-info":[{"award-number":["30870523"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30700334"],"award-info":[{"award-number":["30700334"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"crossref","award":["KSCX2-YW-R-097"],"award-info":[{"award-number":["KSCX2-YW-R-097"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Commission of Shanghai","award":["08JC1413400"],"award-info":[{"award-number":["08JC1413400"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.cbi.2009.09.012","type":"journal-article","created":{"date-parts":[[2009,9,24]],"date-time":"2009-09-24T06:24:00Z","timestamp":1253773440000},"page":"222-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Synergistic mitosis-arresting effects of arsenic trioxide and paclitaxel on human malignant lymphocytes"],"prefix":"10.1016","volume":"183","author":[{"given":"Xu-Fang","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Li","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Zhang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Yi","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.cbi.2009.09.012_bib1","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1182\/blood.V89.9.3354","article-title":"Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients","volume":"89","author":"Shen","year":"1997","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.cbi.2009.09.012_bib2","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJM199811053391901","article-title":"Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide","volume":"339","author":"Soignet","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.cbi.2009.09.012_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cbi.2004.05.002","article-title":"Inhibition of proliferation and induction of apoptosis by 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide in adult T-cell leukemia cells","volume":"148","author":"Harakeh","year":"2004","journal-title":"Chem. Biol. Interact."},{"issue":"2\u20133","key":"10.1016\/j.cbi.2009.09.012_bib4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cbi.2008.12.015","article-title":"Combination treatment with arsenic trioxide and irradiation enhances apoptotic effects in U937 cells through increased mitotic arrest and ROS generation","volume":"179","author":"Ho","year":"2009","journal-title":"Chem. Biol. Interact."},{"issue":"Suppl. 2","key":"10.1016\/j.cbi.2009.09.012_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1634\/theoncologist.6-suppl_2-22","article-title":"Clinical trials of arsenic trioxide in hematologic and solid tumors: overview of the National Cancer Institute Cooperative Research and Development Studies","volume":"6","author":"Murgo","year":"2001","journal-title":"Oncologist"},{"issue":"9","key":"10.1016\/j.cbi.2009.09.012_bib6","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/sj.leu.2402599","article-title":"Clinical activity of arsenic trioxide for the treatment of multiple myeloma","volume":"16","author":"Munshi","year":"2002","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.cbi.2009.09.012_bib7","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.cdd.4401389","article-title":"Effective treatment of advanced solid tumors by the combination of arsenic trioxide and l-buthionine-sulfoximine","volume":"11","author":"Maeda","year":"2004","journal-title":"Cell Death Differ."},{"issue":"9","key":"10.1016\/j.cbi.2009.09.012_bib8","first-page":"1002","article-title":"Might arsenic trioxide be useful in the treatment of advanced myelodysplastic syndromes?","volume":"85","author":"Donelli","year":"2000","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.cbi.2009.09.012_bib9","first-page":"3345","article-title":"Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells","volume":"89","author":"Chen","year":"1997","journal-title":"Blood"},{"issue":"2 Suppl. 1","key":"10.1016\/j.cbi.2009.09.012_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/shem.2002.33611","article-title":"Expanding the use of arsenic trioxide: leukemias and beyond","volume":"39","author":"Chen","year":"2002","journal-title":"Semin. Hematol."},{"issue":"Suppl. 1","key":"10.1016\/j.cbi.2009.09.012_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1634\/theoncologist.7-suppl_1-1","article-title":"Advances in the management of acute promyelocytic leukemia and other hematologic malignancies with arsenic trioxide","volume":"7","author":"Slack","year":"2002","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.cbi.2009.09.012_bib12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1054\/blre.2001.0160","article-title":"Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignancies","volume":"15","author":"Tallman","year":"2001","journal-title":"Blood Rev."},{"issue":"7","key":"10.1016\/j.cbi.2009.09.012_bib13","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/sj.leu.2402983","article-title":"Arsenic trioxide-induced mitotic arrest and apoptosis in acute promyelocytic leukemia cells","volume":"17","author":"Cai","year":"2003","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.cbi.2009.09.012_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4161\/cc.1.3.126","article-title":"Arsenic trioxide arrests cells early in mitosis leading to apoptosis","volume":"1","author":"Halicka","year":"2002","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.cbi.2009.09.012_bib15","first-page":"776","article-title":"Arsenic targets tubulins to induce apoptosis in myeloid leukemia cells","volume":"59","author":"Li","year":"1999","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.cbi.2009.09.012_bib16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1124\/mol.62.3.529","article-title":"Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines","volume":"62","author":"Ling","year":"2002","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.cbi.2009.09.012_bib17","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/jcb.21861","article-title":"Requirement of a functional spindle checkpoint for arsenite-induced apoptosis","volume":"105","author":"Wu","year":"2008","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.cbi.2009.09.012_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/carcin\/bgh295","article-title":"Arsenite induces prominent mitotic arrest via inhibition of G2 checkpoint activation in CGL-2 cells","volume":"26","author":"Yih","year":"2005","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.cbi.2009.09.012_bib19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/1568009033481967","article-title":"Taxanes: microtubule and centrosome targets, and cell cycle dependent mechanisms of action","volume":"3","author":"Abal","year":"2003","journal-title":"Curr. Cancer Drug Targets"},{"issue":"16","key":"10.1016\/j.cbi.2009.09.012_bib20","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.1128\/MCB.23.16.5556-5571.2003","article-title":"Silencing of the novel p53 target gene Snk\/Plk2 leads to mitotic catastrophe in paclitaxel (taxol)-exposed cells","volume":"23","author":"Burns","year":"2003","journal-title":"Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.cbi.2009.09.012_bib21","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.4161\/cc.4.10.2061","article-title":"Low concentrations of taxol cause mitotic delay followed by premature dissociation of p55CDC from Mad2 and BubR1 and abrogation of the spindle checkpoint, leading to aneuploidy","volume":"4","author":"Ikui","year":"2005","journal-title":"Cell Cycle"},{"issue":"16","key":"10.1016\/j.cbi.2009.09.012_bib22","first-page":"5095","article-title":"Transcriptional profiling of targets for combination therapy of lung carcinoma with paclitaxel and mitogen-activated protein\/extracellular signal-regulated kinase kinase inhibitor","volume":"63","author":"Taxman","year":"2003","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.cbi.2009.09.012_bib23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1317","article-title":"Microtubules as a target for anticancer drugs","volume":"4","author":"Jordan","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.cbi.2009.09.012_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1023\/A:1022984830258","article-title":"Phase II study of single agent paclitaxel in adult patients with relapsed acute lymphocytic leukemia","volume":"21","author":"Colburn","year":"2003","journal-title":"Invest. New Drugs"},{"issue":"9","key":"10.1016\/j.cbi.2009.09.012_bib25","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/jnci\/91.9.772","article-title":"Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations","volume":"91","author":"Zhu","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.cbi.2009.09.012_bib26","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1182\/blood-2006-12-060970","article-title":"Low-dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathway","volume":"110","author":"Bornhauser","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cbi.2009.09.012_bib27","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3324\/haematol.10968","article-title":"Arsenic trioxide induces accumulation of cytotoxic levels of ceramide in acute promyelocytic leukemia and adult T-cell leukemia\/lymphoma cells through de novo ceramide synthesis and inhibition of glucosylceramide synthase activity","volume":"92","author":"Dbaibo","year":"2007","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.cbi.2009.09.012_bib28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00109-008-0314-6","article-title":"Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13","volume":"86","author":"Merkel","year":"2008","journal-title":"J. Mol. Med. (Berlin, Germany)"},{"issue":"3","key":"10.1016\/j.cbi.2009.09.012_bib29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cbi.2009.09.012_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose\u2013effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzyme Regul."},{"issue":"11","key":"10.1016\/j.cbi.2009.09.012_bib31","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1080\/10428190802353591","article-title":"Preclinical versus clinical drug combination studies","volume":"49","author":"Chou","year":"2008","journal-title":"Leuk. Lymphoma"},{"issue":"3","key":"10.1016\/j.cbi.2009.09.012_bib32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/emboj\/19.3.379","article-title":"Core histone N-termini play an essential role in mitotic chromosome condensation","volume":"19","author":"de la Barre","year":"2000","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.cbi.2009.09.012_bib33","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1128\/MCB.22.3.874-885.2002","article-title":"Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases","volume":"22","author":"Crosio","year":"2002","journal-title":"Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.cbi.2009.09.012_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/01.pas.0000183572.94140.43","article-title":"Two mitosis-specific antibodies, MPM-2 and phospho-histone H3 (Ser28), allow rapid and precise determination of mitotic activity","volume":"30","author":"Tapia","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"issue":"13","key":"10.1016\/j.cbi.2009.09.012_bib35","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1073\/pnas.86.13.4982","article-title":"Mitosis-specific monoclonal antibody MPM-2 inhibits Xenopus oocyte maturation and depletes maturation-promoting activity","volume":"86","author":"Kuang","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2009.09.012_bib36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0074-7696(08)60250-8","article-title":"Microtubule dynamics during the cell cycle: the effects of taxol and nocodazole on the microtubule system of Pt K2 cells at different stages of the mitotic cycle","volume":"101","author":"De Brabander","year":"1986","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.cbi.2009.09.012_bib37","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.bi.61.070192.002301","article-title":"Animal cell cycles and their control","volume":"61","author":"Norbury","year":"1992","journal-title":"Annu. Rev. Biochem."},{"issue":"3","key":"10.1016\/j.cbi.2009.09.012_bib38","first-page":"1675","article-title":"Mechanisms of p34cdc2 regulation","volume":"13","author":"Atherton-Fessler","year":"1993","journal-title":"Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.cbi.2009.09.012_bib39","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1002\/j.1460-2075.1995.tb07180.x","article-title":"Regulation of the human WEE1Hu CDK tyrosine 15-kinase during the cell cycle","volume":"14","author":"Watanabe","year":"1995","journal-title":"EMBO J."},{"issue":"9","key":"10.1016\/j.cbi.2009.09.012_bib40","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1101\/gad.9.9.1046","article-title":"Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation","volume":"9","author":"Galaktionov","year":"1995","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.cbi.2009.09.012_bib41","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0092-8674(95)90405-0","article-title":"Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling","volume":"80","author":"Hunter","year":"1995","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cbi.2009.09.012_bib42","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/j.1460-2075.1993.tb05633.x","article-title":"Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15","volume":"12","author":"McGowan","year":"1993","journal-title":"EMBO J."},{"issue":"12","key":"10.1016\/j.cbi.2009.09.012_bib43","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1038\/sj.leu.2401939","article-title":"Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983\u20131995","volume":"14","author":"Gaynon","year":"2000","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.cbi.2009.09.012_bib44","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia","volume":"354","author":"Pui","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.cbi.2009.09.012_bib45","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/MOH.0b013e3283034697","article-title":"Progress in the treatment of adults with acute lymphoblastic leukemia","volume":"15","author":"Larson","year":"2008","journal-title":"Curr. Opin. Hematol."},{"issue":"38","key":"10.1016\/j.cbi.2009.09.012_bib46","doi-asserted-by":"crossref","first-page":"23399","DOI":"10.1016\/S0021-9258(17)31528-4","article-title":"How taxol modulates microtubule disassembly","volume":"269","author":"Caplow","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cbi.2009.09.012_bib47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/1097-0169(200010)47:2<81::AID-CM1>3.0.CO;2-#","article-title":"Aneuploidy, the somatic mutation that makes cancer a species of its own","volume":"47","author":"Duesberg","year":"2000","journal-title":"Cell Motil. Cytoskeleton"},{"key":"10.1016\/j.cbi.2009.09.012_bib48","first-page":"S231","article-title":"Protein dynamics at the kinetochore: cell cycle regulation of the metaphase to anaphase transition","volume":"13 Suppl. 2","author":"Gorbsky","year":"1999","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.cbi.2009.09.012_bib49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ncb0306-209","article-title":"How APC\/C orders destruction","volume":"8","author":"Buschhorn","year":"2006","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.cbi.2009.09.012_bib50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.molcel.2004.09.031","article-title":"Phosphorylation of Cdc20 by Bub1 provides a catalytic mechanism for APC\/C inhibition by the spindle checkpoint","volume":"16","author":"Tang","year":"2004","journal-title":"Mol. Cell"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279709003937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279709003937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:20:04Z","timestamp":1757856004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279709003937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0009279709003937"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2009.09.012","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic mitosis-arresting effects of arsenic trioxide and paclitaxel on human malignant lymphocytes","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2009.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}